K
Karin Tse
Researcher at Lupus Foundation of America
Publications - 5
Citations - 41
Karin Tse is an academic researcher from Lupus Foundation of America. The author has contributed to research in topics: Tolerability & Hydroxychloroquine. The author has an hindex of 2, co-authored 5 publications receiving 17 citations.
Papers
More filters
Journal ArticleDOI
Global consensus building and prioritisation of fundamental lupus challenges: the ALPHA project.
Susan Manzi,Sandra Raymond,Karin Tse,Yaritza Peña,Annick Anderson,Kathleen Arntsen,Sang Cheol Bae,Ian N. Bruce,Thomas Dörner,Kenneth A. Getz,Leslie Hanrahan,Amy H. Kao,Eric F Morand,Brad H. Rovin,Laura E. Schanberg,Joan M. Von Feldt,Victoria P. Werth,Karen H. Costenbader +17 more
TL;DR: The Addressing Lupus Pillars for Health Advancement (ALPHA) project is the first step in establishing global consensus and developing concrete strategies to address the challenges limiting progress, and provides a framework to generate actionable approaches to the identified high-priority barriers.
Journal ArticleDOI
Hydroxychloroquine usage in US patients, their experiences of tolerability and adherence, and implications for treatment: survey results from 3127 patients with SLE conducted by the Lupus Foundation of America.
TL;DR: The majority of patients with SLE in the USA have been prescribed hydroxychloroquine (HCQ), but the availability of only one strength (200 mg tablets) may limit the flexibility and ability to accurately dose patients with lupus.
Journal ArticleDOI
The ALPHA Project: Establishing consensus and prioritisation of global community recommendations to address major challenges in lupus diagnosis, care, treatment and research.
Karin Tse,Sanjyot Sangodkar,Lauren Bloch,Kathleen Arntsen,Sang Cheol Bae,Ian N. Bruce,Erin Connolly-Strong,Karen H. Costenbader,Bradley Dickerson,Thomas Dörner,Sydney Evans,Kenneth C. Kalunian,Amy H. Kao,Susan Manzi,Eric F Morand,Sandra Raymond,Brad H. Rovin,Laura E. Schanberg,Joan M. Von Feldt,Victoria P. Werth,Victoria P. Werth,Angel Williams Derricott,David Zook,Timothy Franson,Kenneth A. Getz,Yaritza Peña,Leslie Hanrahan +26 more
TL;DR: The Addressing Lupus Pillars for Health Advancement (ALPHA) Project is a global consensus effort to identify, prioritise and address top barriers in lupus impacting diagnosis, care, treatment and research as discussed by the authors.
Journal ArticleDOI
Patient Experiences, Satisfaction, and Expectations with Current Systemic Lupus Erythematosus Treatment: Results of the SLE-UPDATE Survey
Julie Birt,M Hadi,Nashmel Sargalo,Ella Brookes,Paul Swinburn,Leslie Hanrahan,Karin Tse,N. Bello,Kirstin Griffing,Maria E. Silk,Laure Delbecque,Diane L. Kamen,Anca Askanase +12 more
TL;DR: In this article, a survey of US adult patients with systemic lupus erythematosus (SLE) was conducted in 2019, which consisted of 104 questions about SLE and the following PRO instruments: LupusPRO™, Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue, Work Productivity and Activity Impairment (WPAI), an 11-point Worst Pain Numerical Rating scale (NRS), and an 11point Worst Joint Pain NRS.
Journal ArticleDOI
Establishing Consensus Understanding of the Barriers to Drug Development in Lupus.
TL;DR: The study findings encourage drug development professionals to validate disease-specific measures and to identify if specific symptoms are caused by lupus and provide a methodology that can be applied to highly heterogenous diseases where low consensus on diagnosis and treatment exists among drug development and health professionals.